Novavax Stock Price History
NVAX Stock | USD 8.47 0.43 5.35% |
Below is the normalized historical share price chart for Novavax extending back to December 05, 1995. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Novavax stands at 8.47, as last reported on the 24th of November, with the highest price reaching 8.62 and the lowest price hitting 8.00 during the day.
If you're considering investing in Novavax Stock, it is important to understand the factors that can impact its price. Novavax has Sharpe Ratio of -0.06, which conveys that the firm had a -0.06% return per unit of risk over the last 3 months. Novavax exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Novavax's Standard Deviation of 5.41, mean deviation of 3.61, and Risk Adjusted Performance of (0.04) to check out the risk estimate we provide.
At this time, Novavax's Common Stock Shares Outstanding is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 1.9 B in 2024, despite the fact that Total Stockholder Equity is likely to grow to (681.1 M). . Price Earnings To Growth Ratio is likely to rise to 0.03 in 2024, whereas Price To Sales Ratio is likely to drop 0.47 in 2024. Novavax Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 5th of December 1995 | 200 Day MA 10.1313 | 50 Day MA 10.8054 | Beta 2.088 |
Novavax |
Sharpe Ratio = -0.06
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | NVAX |
Estimated Market Risk
5.43 actual daily | 48 52% of assets are more volatile |
Expected Return
-0.33 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Novavax is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Novavax by adding Novavax to a well-diversified portfolio.
Price Book 49.522 | Enterprise Value Ebitda (0.53) | Price Sales 1.5327 | Shares Float 143.4 M | Wall Street Target Price 16 |
Novavax Stock Price History Chart
There are several ways to analyze Novavax Stock price data. The simplest method is using a basic Novavax candlestick price chart, which shows Novavax price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | October 2, 2024 | 14.68 |
Lowest Price | November 14, 2024 | 7.22 |
Novavax November 24, 2024 Stock Price Synopsis
Various analyses of Novavax's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Novavax Stock. It can be used to describe the percentage change in the price of Novavax from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Novavax Stock.Novavax Price Action Indicator | 0.38 | |
Novavax Price Rate Of Daily Change | 1.05 | |
Novavax Price Daily Balance Of Power | 0.69 |
Novavax November 24, 2024 Stock Price Analysis
Novavax Stock Price History Data
The price series of Novavax for the period between Mon, Aug 26, 2024 and Sun, Nov 24, 2024 has a statistical range of 7.46 with a coefficient of variation of 17.27. The daily prices for the period are spread out with arithmetic mean of 11.11. The median price for the last 90 days is 11.87. The company underwent 1:20 stock split on 10th of May 2019. Novavax issued dividends to stockholders on 2019-05-10.Open | High | Low | Close | Volume | ||
11/24/2024 | 8.06 | 8.62 | 8.00 | 8.47 | ||
11/22/2024 | 8.06 | 8.62 | 8.00 | 8.47 | 4,787,350 | |
11/21/2024 | 8.00 | 8.34 | 7.96 | 8.04 | 3,152,324 | |
11/20/2024 | 8.00 | 8.15 | 7.76 | 8.06 | 3,465,620 | |
11/19/2024 | 7.80 | 8.10 | 7.65 | 8.00 | 4,250,704 | |
11/18/2024 | 7.41 | 8.01 | 7.37 | 7.83 | 6,887,776 | |
11/15/2024 | 7.14 | 7.33 | 6.81 | 7.32 | 9,341,324 | |
11/14/2024 | 7.80 | 7.94 | 7.17 | 7.22 | 8,997,622 | |
11/13/2024 | 8.44 | 8.56 | 7.76 | 7.77 | 7,377,013 | |
11/12/2024 | 8.05 | 8.90 | 7.89 | 8.46 | 10,804,266 | |
11/11/2024 | 9.89 | 10.39 | 8.90 | 9.01 | 14,629,101 | |
11/08/2024 | 9.25 | 9.25 | 8.84 | 8.91 | 3,764,074 | |
11/07/2024 | 9.16 | 9.34 | 8.99 | 9.18 | 3,085,824 | |
11/06/2024 | 9.06 | 9.27 | 8.43 | 8.96 | 6,499,486 | |
11/05/2024 | 9.00 | 9.48 | 8.86 | 9.44 | 3,469,643 | |
11/04/2024 | 9.20 | 9.30 | 8.90 | 9.12 | 4,245,371 | |
11/01/2024 | 9.69 | 9.87 | 9.29 | 9.35 | 4,424,403 | |
10/31/2024 | 9.83 | 9.90 | 9.51 | 9.61 | 3,555,599 | |
10/30/2024 | 10.00 | 10.07 | 9.71 | 9.84 | 4,001,066 | |
10/29/2024 | 10.24 | 10.63 | 9.88 | 10.07 | 4,527,925 | |
10/28/2024 | 9.90 | 10.48 | 9.73 | 10.25 | 5,133,774 | |
10/25/2024 | 9.90 | 9.92 | 9.52 | 9.74 | 5,008,140 | |
10/24/2024 | 10.00 | 10.15 | 9.85 | 9.92 | 3,537,639 | |
10/23/2024 | 10.10 | 10.24 | 9.92 | 10.00 | 3,380,416 | |
10/22/2024 | 10.14 | 10.35 | 10.01 | 10.12 | 3,528,176 | |
10/21/2024 | 10.10 | 10.22 | 9.90 | 10.14 | 4,787,219 | |
10/18/2024 | 10.40 | 10.80 | 10.10 | 10.18 | 7,044,766 | |
10/17/2024 | 10.16 | 10.42 | 9.87 | 10.35 | 9,856,751 | |
10/16/2024 | 10.43 | 10.67 | 9.62 | 10.15 | 32,303,448 | |
10/15/2024 | 12.67 | 12.86 | 12.38 | 12.60 | 3,302,033 | |
10/14/2024 | 12.43 | 13.34 | 12.23 | 12.62 | 5,635,240 | |
10/11/2024 | 12.72 | 13.04 | 12.34 | 12.53 | 5,767,285 | |
10/10/2024 | 12.60 | 13.33 | 12.60 | 12.91 | 4,467,858 | |
10/09/2024 | 13.17 | 13.35 | 12.60 | 12.68 | 6,056,475 | |
10/08/2024 | 12.98 | 13.61 | 12.94 | 13.04 | 3,487,178 | |
10/07/2024 | 13.72 | 13.77 | 12.83 | 13.02 | 4,574,992 | |
10/04/2024 | 14.46 | 14.70 | 13.18 | 13.61 | 7,526,560 | |
10/03/2024 | 14.07 | 15.09 | 14.01 | 14.42 | 6,994,711 | |
10/02/2024 | 12.32 | 15.22 | 12.18 | 14.68 | 17,494,674 | |
10/01/2024 | 12.60 | 12.66 | 11.71 | 12.32 | 6,393,549 | |
09/30/2024 | 13.21 | 13.45 | 12.62 | 12.63 | 4,123,954 | |
09/27/2024 | 12.32 | 13.48 | 12.15 | 13.30 | 7,027,058 | |
09/26/2024 | 12.27 | 12.46 | 11.95 | 12.15 | 3,857,195 | |
09/25/2024 | 13.66 | 14.17 | 11.90 | 12.04 | 11,725,432 | |
09/24/2024 | 12.86 | 13.68 | 12.62 | 13.29 | 6,556,030 | |
09/23/2024 | 13.01 | 13.30 | 12.69 | 12.80 | 3,969,542 | |
09/20/2024 | 12.52 | 13.36 | 12.34 | 12.91 | 8,921,294 | |
09/19/2024 | 12.79 | 13.13 | 12.35 | 12.52 | 4,998,929 | |
09/18/2024 | 12.95 | 13.38 | 12.42 | 12.56 | 5,716,638 | |
09/17/2024 | 13.32 | 13.90 | 12.70 | 12.93 | 6,146,756 | |
09/16/2024 | 13.61 | 13.83 | 13.11 | 13.20 | 5,555,715 | |
09/13/2024 | 11.87 | 14.03 | 11.82 | 13.61 | 12,196,040 | |
09/12/2024 | 11.75 | 12.17 | 11.09 | 11.92 | 5,769,257 | |
09/11/2024 | 12.70 | 12.91 | 11.98 | 12.29 | 4,778,399 | |
09/10/2024 | 12.75 | 12.89 | 12.24 | 12.70 | 3,247,253 | |
09/09/2024 | 11.76 | 12.84 | 11.71 | 12.78 | 5,404,456 | |
09/06/2024 | 11.91 | 12.12 | 11.43 | 11.63 | 2,761,080 | |
09/05/2024 | 11.86 | 12.10 | 11.26 | 11.95 | 3,774,236 | |
09/04/2024 | 12.58 | 13.84 | 11.64 | 11.87 | 12,157,888 | |
09/03/2024 | 12.29 | 13.20 | 12.26 | 12.67 | 8,555,970 | |
08/30/2024 | 11.45 | 12.49 | 11.13 | 12.38 | 9,808,097 |
About Novavax Stock history
Novavax investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Novavax is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Novavax will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Novavax stock prices may prove useful in developing a viable investing in Novavax
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 100.8 M | 105.8 M | |
Net Loss | -592.1 M | -562.5 M |
Novavax Stock Technical Analysis
Novavax technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Alpha Finder Now
Alpha FinderUse alpha and beta coefficients to find investment opportunities after accounting for the risk |
All Next | Launch Module |
Novavax Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Novavax's price direction in advance. Along with the technical and fundamental analysis of Novavax Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Novavax to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.04) | |||
Jensen Alpha | (0.46) | |||
Total Risk Alpha | (1.24) | |||
Treynor Ratio | (0.63) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for Novavax Stock Analysis
When running Novavax's price analysis, check to measure Novavax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novavax is operating at the current time. Most of Novavax's value examination focuses on studying past and present price action to predict the probability of Novavax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novavax's price. Additionally, you may evaluate how the addition of Novavax to your portfolios can decrease your overall portfolio volatility.